Medifast (MED) Asset Writedowns and Impairment (2011 - 2020)

Medifast (MED) has 7 years of Asset Writedowns and Impairment data on file, last reported at $48000.0 in Q4 2020.

• Quarterly Asset Writedowns and Impairment fell 88.81% year-over-year to $48000.0 in Q4 2020, while the trailing twelve-month figure through Dec 2020 was $7.0 million (up 0.69% YoY) and the FY2020 annual result came in at $556000.0, down 84.72% from the prior year.
• Asset Writedowns and Impairment slipped to $48000.0 in Q4 2020, from $429000.0 in the prior quarter.
• In the past five years, Asset Writedowns and Impairment ranged from a high of $6.1 million in Q2 2016 to a low of $48000.0 in Q4 2020.
• A 5-year average of $2.6 million and a median of $429000.0 in 2019 frame the typical range for Asset Writedowns and Impairment.
• Annual changes were most pronounced in 2019 — Asset Writedowns and Impairment increased 3.12% — and 2020, when it plunged 88.81%.
• Tracing MED's Asset Writedowns and Impairment over 5 years: stood at $6.1 million in 2016, then changed by 0.0% to $6.1 million in 2017, then sank by 93.18% to $416000.0 in 2018, then advanced by 3.12% to $429000.0 in 2019, then sank by 88.81% to $48000.0 in 2020.
• The last three Asset Writedowns and Impairment figures came in at $48000.0 (Q4 2020), $429000.0 (Q4 2019), and $416000.0 (Q4 2018), per Business Quant data.